Excess cancers among HIV-infected people in the United States. - Test2 - elhamkhani - TriplyDB

Excess cancers among HIV-infected people in the United States.

Excess cancers among HIV-infected people in the United States.

http://www.wikidata.org/entity/Q35102629

about

HIV, Aging, and Viral Coinfections: Taking the Long View.Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.Long-term nitrite inhalant exposure and cancer risk in MSM.Single-institutional experience of clinicopathological analysis and treatment for lung cancer patients with human immunodeficiency virus infection.Multiple cause-of-death data among people with AIDS in Italy: a nationwide cross-sectional study.Evolving epidemiology of HIV-associated malignancies.HAART and lungs: do HIV protease inhibitors impact cancer risk?Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study.Malignancies, Particularly B-Cell Lymphomas, Are a Frequent Cause of Mortality in Human Immunodeficiency Virus-1 Patients Despite Highly Active Antiretroviral Therapy Cancers attributable to infections among adults with HIV in the United States.Herpes Zoster and Risk of Cancer in the Elderly U.S. Population.Cancer prevention in HIV-infected populations.Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.Role of Natural Killer Cells in HIV-Associated Malignancies.T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.Cervical cancer incidence after up to 20 years of observation among women with HIV.Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Deaths Due to Screenable Cancers Among People Living With HIV Infection, Florida, 2000-2014.Excess Mortality among HIV-Infected Individuals with Cancer in the United States.Astrocyte Elevated Gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease Project ACCRUE: Exploring Options to Increase Awareness of AIDS Malignancy Consortium Clinical Trials in North Carolina.Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.Lung cancer in persons with HIV.Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa.Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.Screening for Cancer in Persons Living with HIV Infection.HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy.Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection.Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.Cancer burden attributable to cigarette smoking among HIV-infected people in North America.Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.

P2860

Q30245486-4A003EEA-EEE1-4D92-BF7C-07DE55BC0E44 Q30491585-6EC793C6-7949-4AEF-9418-19F4F10820D6 Q33631041-68F4BADF-4198-4FBC-A724-CCC4E67AA17F Q33684235-371AAFFB-B870-4FEA-9AC0-6E6FAE85F04F Q33706218-B33FD3FF-DC01-48AC-9203-5E51C118EBE6 Q34679292-C881DF7E-39F8-4008-8181-40ED0A721676 Q35825813-85E812EF-8F3F-41C1-974F-0932F048BD34 Q36030989-7A2FBCBD-7976-4371-AB43-7DC7485D88BB Q36120745-AE63338E-C99B-4CED-8413-6EC44493542E Q36241641-92326959-7EE3-45EA-9AF8-3ED8A19290F2 Q36259445-11FA2DCC-1B4F-499F-980E-A7592B5C3D4C Q36463623-8236B6F2-F8ED-475D-A704-A51AA72F39C6 Q36680086-EEE9CA3F-132D-48E2-B1D2-9761E13EF046 Q37416478-A11871D8-40DD-404E-AF7F-4899362B134B Q37712593-11F1757B-A405-4DA8-B3DF-D8A5FECAB189 Q38376433-545D3CD0-FE27-41C5-A463-0D2891393982 Q38400222-0192DA56-CEEF-4476-A4E3-34B7B1FFF394 Q38447992-ACF102D2-C307-4803-B33E-15A6FB8BC8C2 Q38656803-16806F89-242F-416B-9AC4-8DC72EFD55BF Q38723336-0740D711-81D2-469D-B16D-B3AF1FF4771B Q38811225-DBB45916-F0B5-495D-80F4-378EF12DB495 Q38831232-E7B2AC1E-905A-4139-9B53-276C8B6C79EC Q38831450-D4631756-355E-4ED1-A623-311BCBD722E2 Q38933905-7A126CB2-C3AD-49D3-AEE2-A915ADF35392 Q38943741-B99BCB32-0888-442D-ACBD-239FC15BF25B Q38949456-DFE7A456-E3DC-4B62-BE3D-D2B716819AA6 Q38988920-A5E7CE30-A283-43D6-A776-45DB1950E115 Q39020800-764DCA0E-A3B3-4965-9332-4728EE0621B6 Q39021760-D14111C0-5D9C-4C9C-B94D-86F9BEB04AA3 Q39111243-609C212D-F222-492F-A155-37C535B1D457 Q39508906-77A696EC-E03D-408D-8BE3-3EEBA7C3D69C Q40116637-200B72A7-BD6F-4E79-B132-E155874251E4 Q40223990-E83DE5AC-F645-41D8-96D5-F299699BA91F Q40250347-AD227A45-B34C-4449-B6B1-F557C11C3776 Q40533645-07E39D69-8297-4521-8702-BCBE620FFA5A Q40701232-0ECCE6A0-4ADA-4380-A330-9ADA04AF7965 Q41393034-1E4192B0-10DD-43B1-88FA-50F608EA53DE Q45324643-9295F5D7-E329-418C-A5CB-2D5BD8F2B6A3 Q45981767-C8A585E0-465A-4686-8A46-06EC9CB5789F Q46335294-D11BE038-35F8-415D-B313-6956CA7CF00C

P2860

Excess cancers among HIV-infected people in the United States.

http://www.wikidata.org/entity/Q35102629

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Excess cancers among HIV-infected people in the United States.

@ast

Excess cancers among HIV-infected people in the United States.

@en

type

label

Excess cancers among HIV-infected people in the United States.

@ast

Excess cancers among HIV-infected people in the United States.

@en

prefLabel

Excess cancers among HIV-infected people in the United States.

@ast

Excess cancers among HIV-infected people in the United States.

@en

P1433

Q35102629-F0162FE2-E047-4789-B372-3DEAF6470BEA

P1476

Q35102629-1E3EBDFB-79CD-49F4-837E-EC3D023089AF

P2093

Q35102629-162F1ED2-7BEC-400A-AB39-9DE91F4D7AA3

Q35102629-2945B088-8425-4314-8B13-DA430A4F03A7

Q35102629-5300508A-DDD4-45D8-A994-EA608586AD5D

Q35102629-5E95AED7-25B9-45B3-B701-477E2798E3FC

Q35102629-D7730747-65C9-4EDF-B140-33E01AF5369C

Q35102629-F0C22C04-978C-473F-9746-5CA9DF11FD33

P2860

Q35102629-00818BDD-13A7-47BE-8B81-69BC5384DA62

Q35102629-10BECB70-203F-4284-995D-5EFABF4965F2

Q35102629-132F0E1F-C221-4BF3-9FE0-E6134CDA7441

Q35102629-25B381C6-9B3D-4DA9-B34E-D35D7AA598AB

Q35102629-2A627A96-1BA1-489F-803A-374AACD0AC5B

Q35102629-2A8DDDE0-F8D0-4019-A171-00268B4383BD

Q35102629-2C5D1BBB-0D3A-4714-8150-25C6CDB301E9

Q35102629-327627E4-C9D1-4A2F-BA11-C4B030C95135

Q35102629-3B0EC503-179D-4672-AF93-6DA9E62BDBF3

Q35102629-3C81AA19-6D77-48D9-B266-68F402DF9887

P31

Q35102629-E3E18916-02DB-4FFC-98FF-89E50B5BAE05

P356

Q35102629-1EC4C071-CF8A-4AF7-B82B-23A317F43D6E

P407

Q35102629-2A709347-3489-4BBF-84D6-CCCD530A4F68

P433

Q35102629-642C7733-4243-44A6-A523-430DEA73CDB5

P478

Q35102629-DFB59238-36C5-4329-A69D-72811847B2FE

P577

Q35102629-ED77EF90-055C-42B8-A795-0E75F9417CDE

P698

Q35102629-C9B2250A-8808-4A12-8669-C78B4206FD05

P921

Q35102629-7C722573-9F54-4E6F-80B9-B8C0C73BCBA1

P932

Q35102629-A6C9E115-D978-47CB-9425-1768324B9E1A

P356

P1433

Journal of the National Cancer Institute

P1476

Excess cancers among HIV-infected people in the United States.

@en

P2093

Eric A Engels

http://www.w3.org/2001/XMLSchema#string

H Irene Hall

http://www.w3.org/2001/XMLSchema#string

Hilary A Robbins

http://www.w3.org/2001/XMLSchema#string

Jianmin Li

http://www.w3.org/2001/XMLSchema#string

Meredith S Shiels

http://www.w3.org/2001/XMLSchema#string

Ruth M Pfeiffer

http://www.w3.org/2001/XMLSchema#string

P2860

Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study

Reduced lung-cancer mortality with low-dose computed tomographic screening

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Spectrum of cancer risk late after AIDS onset in the United States.

Reduced risk of prostate cancer in U.S. Men with AIDS.

Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users.

P31

scholarly article

P356

10.1093/JNCI/DJU503

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25663691

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

4334816

http://www.w3.org/2001/XMLSchema#string